Purchase Order HHSN272201100404P
Award Date 3/24/11
Potential Completion Date 9/30/11
Potential Value $12K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Bethesda, MD 20892, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
3
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- <p>This federal contract award with ID HHSN272201200386P was made by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services, to the small business contractor IG Assets Inc. The $99,750.00 firm fixed-price purchase order contract was awarded on April 10, 2012 with a completion date of April 28, 2013. The contract is designated as a total small business set-aside.</p>
- The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases Division of Allergy, Immunology and Transplantation awarded a $13,100 fixed price level of effort purchase order to Biolab Net for BIOLAB NET - AMBIS# 926121. The contract has a period of performance from February 26, 2010 through March 28, 2010 for work to be conducted in Bethesda, Maryland. No major subcontractors or set aside designations were identified. This...
- This federal contract award, identified as HHSN272201501390P, was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the Department of Health and Human Services. The $6,130.60 firm-fixed-price purchase order was awarded to Invivogen, a for-profit organization, on September 23, 2015 for the product "AMBIS 1755049 ODN1826, 5MG; PRODUCT ID TLRL-1826-5." The contract did not have a set-aside designation and is scheduled for completion on...
- <p>This $23,991.00 firm fixed price purchase order was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services, to Protein Biosolutions Inc. on May 8, 2014. The contract is for AMBIS # 1678920 SEQUENCING services, with a period of performance ending on June 20, 2014. The contract was not set aside for any specific business type.</p>
- <p>This is a firm-fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. Department of Health and Human Services, to Protein Biosolutions Inc. The contract, valued at $8,700.00, is for AMBIS # 1662465 TESTING services. The contract has a period of performance ending on March 28, 2014 and was awarded on January 30, 2014. This is not a set-aside contract.</p>
- The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $164.1 million delivery order contract to Technical Resources International, Inc. (TRI), a minority-owned, woman-owned, and Hispanic American-owned small business based in Bethesda, Maryland. The contract, awarded on April 15, 2024, with a completion date of April 14, 2031, is structured as a cost-plus-fixed-fee delivery order with no set-aside designation, indicating TRI won the award through open competition. This...
- The National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, awarded a Cost Plus Fixed Fee Delivery Order contract worth $2,676,372.00 to Technical Resources International, Inc. (TRI), a minority-owned, woman-owned, Hispanic American-owned small business. The contract is for DAIDS Quality Assurance, Quality Control and Inspection Readiness Support Services under Task Area F of the CARRRP contract vehicle. TRI has significant experience supporting biomedical research...
- This firm fixed-price purchase order was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services, to Bio S. Et T. Inc. for BIO S & T (AMBIS #1602942) services. The $8,798.00 contract has an ultimate completion date of September 30, 2012 and does not have a set-aside designation. No further details about the specific products or services being provided were included in the information provided.
- The federal contract award, HHSN272201600008I|HHSN27200001, was granted by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services, to Advanced Bioscience Laboratories, Inc. (ABL), a for-profit manufacturer of goods. The contract is for $4,669,061.95 and is for quality assurance/quality control (QA/QC) services in support of the NIAID's Comprehensive Resources for HIV Microbicides and Biomedical Prevention...
- This federal contract award is for $17,900 and was issued by the National Institute of Allergy and Infectious Diseases (NIAID), which is part of the National Institutes of Health (NIH), a civilian agency. The contract was awarded to Worklife Performance, Inc., a woman-owned small business, on January 13, 2011 with a period of performance through June 16, 2011. The contract is a firm fixed-price purchase order and does not have a set-aside designation. The award references a previous purchase...
The federal contract award HHSN272201100404P was issued by the National Institute of Allergy and Infectious Diseases (NIAID) to Trionix Research Laboratory, Inc. on March 24, 2011. The $12,000 firm fixed-price purchase order contract has a completion date of September 30, 2011. The contract does not have a set-aside designation. Based on the award description of "TRIONIX (AMBIS #1547194)", this contract is likely for research and development services related to the AMBIS program, which falls under NIAID's mission areas.
Generated 11/24/24, 9:21 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| 1 | Funding Only Action | ($6k) | 9/29/15 | |
| Not listed | Not listed | $18.0k | 3/24/11 |